Published in J Neurol on September 12, 1978
Motor control abnormalities in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 0.81
A general framework for dynamic cortical function: the function-through-biased-oscillations (FBO) hypothesis. Front Hum Neurosci (2015) 0.80
Spatiotemporal dynamics of online motor correction processing revealed by high-density electroencephalography. J Cogn Neurosci (2014) 0.78
Readiness potential of cortical area 6 preceding self paced movement in Parkinson's disease. J Neurol Neurosurg Psychiatry (1987) 0.77
Motivational engagement in Parkinson's disease: Preparation for motivated action. Int J Psychophysiol (2015) 0.75
Ultra-high resolution SPECT system using four pinhole collimators for small animal studies. J Nucl Med (1995) 2.87
Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol (1994) 2.81
The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology (1984) 2.65
Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos (1996) 2.11
Early diffusion MR imaging findings and short-term outcome in comatose patients with hypoglycemia. AJNR Am J Neuroradiol (2012) 2.11
The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery (1995) 2.09
Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol (1979) 2.01
alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem (2001) 1.93
Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther (1996) 1.74
Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet (1995) 1.67
Brain functional activity during gait in normal subjects: a SPECT study. Neurosci Lett (1997) 1.57
IFCN recommended standards for short latency somatosensory evoked potentials. Report of an IFCN committee. International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol (1994) 1.56
Human neurolymphomatosis by adult T-cell leukemia. Neurology (1989) 1.54
Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci (1981) 1.49
Components of the movement-related cortical potential and their scalp topography. Electroencephalogr Clin Neurophysiol (1980) 1.45
A clinical comparative study of multiple sclerosis and neuro-Behçet's syndrome. J Neurol Neurosurg Psychiatry (1980) 1.44
Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology (2012) 1.42
Tremor induced by toluene misuse successfully treated by a Vim thalamotomy. J Neurol Neurosurg Psychiatry (1999) 1.42
Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques. Biochem Biophys Res Commun (1984) 1.41
A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol (1982) 1.39
Hereditary amyloidosis. Arthritis Rheum (1971) 1.38
Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci (1999) 1.37
Peg5/Neuronatin is an imprinted gene located on sub-distal chromosome 2 in the mouse. Nucleic Acids Res (1997) 1.37
Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene. Proc Natl Acad Sci U S A (1998) 1.37
Human PEG1/MEST, an imprinted gene on chromosome 7. Hum Mol Genet (1997) 1.36
Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab Dispos (1998) 1.35
Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology (1975) 1.35
A computer-assisted method for averaging movement-related cortical potentials with respect to EMG onset. Electroencephalogr Clin Neurophysiol (1985) 1.34
Polyneuritic amyloidosis in a Japanese family. Arch Neurol (1968) 1.34
Painful tonic seizure in multiple sclerosis. Arch Neurol (1974) 1.29
Immunologic derangement in myotonic dystrophy--abnormal contact sensitization to dinitrochlorobenzene. J Neurol Sci (1980) 1.29
Brain structures related to active and passive finger movements in man. Brain (1999) 1.29
Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol (1998) 1.28
Electroencephalographic studies myoclonus. Brain (1978) 1.27
Clinical significance of periodic EEG patterns. Arch Neurol (1980) 1.27
Movement-related change of electrocorticographic activity in human supplementary motor area proper. Brain (2000) 1.26
Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans. Clin Pharmacol Ther (2000) 1.23
Identification of PLC210, a Caenorhabditis elegans phospholipase C, as a putative effector of Ras. J Biol Chem (1998) 1.22
Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol (2003) 1.22
Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study. Brain (1999) 1.22
Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci (1999) 1.20
Transient neural activity in the medial superior frontal gyrus and precuneus time locked with attention shift between object features. Neuroimage (1999) 1.20
Ossification of the thoracic posterior longitudinal ligament in a fixed population. Radiological and neurological manifestations. Radiology (1982) 1.19
Tonic vibration reflex and muscle afferent block in writer's cramp. Ann Neurol (1995) 1.19
Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. Brain (1985) 1.17
Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease. J Neurol Sci (1974) 1.17
Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology (1992) 1.16
Activities of the primary and supplementary motor areas increase in preparation and execution of voluntary muscle relaxation: an event-related fMRI study. J Neurosci (1999) 1.16
Simultaneous recording of epileptiform discharges by MEG and subdural electrodes in temporal lobe epilepsy. Neuroimage (1997) 1.15
Neuropathological and biochemical studies in Fabry's disease. Acta Neuropathol (1974) 1.14
Optic atrophy, neural deafness, and distal neurogenic amyotrophy; report of a family with two affected siblings. Arch Neurol (1970) 1.13
Infantile neuroaxonal dystrophy. Ultrastructural study of peripheral nerve. Acta Neuropathol (1976) 1.12
The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem (1996) 1.12
Central vs peripheral nerve conduction. Before and after treatment of subacute combined degeneration. Arch Neurol (1988) 1.12
Dissociable mechanisms of attentional control within the human prefrontal cortex. Cereb Cortex (2001) 1.11
Role of cerebral cortex in human postural control: an EEG study. Clin Neurophysiol (2005) 1.11
Hemispheric infarction after herpes zoster ophthalmicus: computed tomography and angiography. Neurology (1981) 1.10
Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann Neurol (1999) 1.10
Experimental transmission of human subacute spongiform encephalopathy to small rodents. III. Further transmission from three patients and distribution patterns of lesions in mice. Acta Neuropathol (1981) 1.09
Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum Mol Genet (2001) 1.08
Oculomotor abnormalities in Parkinson's disease. Arch Neurol (1979) 1.08
Cortical tremor: a variant of cortical reflex myoclonus. Neurology (1990) 1.08
Movement-related potentials recorded from supplementary motor area and primary motor area. Role of supplementary motor area in voluntary movements. Brain (1992) 1.07
Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res (1994) 1.06
REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation. J Neurol Neurosurg Psychiatry (1997) 1.06
Cortical potentials preceding voluntary movement: evidence for three periods of preparation in man. Electroencephalogr Clin Neurophysiol (1986) 1.06
Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk Res (1997) 1.06
Differential structural requirements for interaction of Ras protein with its distinct downstream effectors. J Biol Chem (1996) 1.06
Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line. Genes Cells (2001) 1.05
Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res (1995) 1.05
Expression and imprinting status of human PEG8/IGF2AS, a paternally expressed antisense transcript from the IGF2 locus, in Wilms' tumors. J Biochem (2000) 1.05
Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens. Neurology (1980) 1.04
Attention modulates both primary and second somatosensory cortical activities in humans: a magnetoencephalographic study. J Neurophysiol (1998) 1.04
Increased synchronization of cortical oscillatory activities between human supplementary motor and primary sensorimotor areas during voluntary movements. J Neurosci (2001) 1.04
Clinical studies of multiple sclerosis in Japan. I. A current appraisal of 83 cases. Neurology (1973) 1.04
Human auditory and somatosensory event-related potentials: effects of response condition and age. Electroencephalogr Clin Neurophysiol (1987) 1.04
Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther (2001) 1.03
Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J Neurosci Res (2001) 1.03
Experimental verification of PbBi2Te4 as a 3D topological insulator. Phys Rev Lett (2012) 1.03
Electroencephalographic correlates of myoclonus. Electroencephalogr Clin Neurophysiol (1975) 1.03
Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases. J Biol Chem (1985) 1.03
Failed levodopa therapy in striato-nigral degeneration. Lancet (1971) 1.02
Myotonic dystrophy and thymoma: a necropsy case report. J Neurol Neurosurg Psychiatry (1981) 1.01
The cortical generators of the contingent negative variation in humans: a study with subdural electrodes. Electroencephalogr Clin Neurophysiol (1997) 1.01
Multiple sclerosis among Orientals and Caucasians in Hawaii: a reappraisal. Neurology (1978) 1.01
A dose-response study with dihydroergotoxine mesylate in cerebrovascular disturbances. J Am Geriatr Soc (1983) 1.01
Characterization of a novel Ras-binding protein Ce-FLI-1 comprising leucine-rich repeats and gelsolin-like domains. Biochem Biophys Res Commun (1999) 1.00
Abnormal premovement gating of somatosensory input in writer's cramp. Brain (2000) 1.00
Mechanisms of pain relief by vibration and movement. J Neurol Neurosurg Psychiatry (1992) 1.00
Use of SEPs to localize degeneration in a rare polyneuropathy: studies on polyneuropathy associated with pigmentation, hypertrichosis, edema, and plasma cell dyscrasia. Ann Neurol (1982) 1.00